Two new deals to start the year and positive trial presentations at the J.P. Morgan Health Care conference have breathed new life into some of last year's biggest stock losers.
FDA Commissioner Scott Gottlieb's keynote address Tuesday was delivered via video conference from Washington, D.C., to thousands of bankers and health executives, and his audio cut out just as he was making a key point on teen nicotine use.
The J.P. Morgan Healthcare Conference, the industry's biggest investor show, will bring more than 485 companies and 9,000 attendees to San Francisco.
Regeneron's CEO is hopeful he can bargain with pharmacy benefit managers to lower the cost of its cholesterol drug for patients.
Sage Therapeutics has to balance two competing interests when pricing its postpartum depression drug, CEO Jeff Jonas says.
Medtronic has "the strongest pipeline that we've ever had in this company," CEO Omar Ishrak tells CNBC's Jim Cramer.
Amazon can reinvent the parts of the health-care system, but it needs to be careful with patient data.
Is there a way "to go directly to the patient with some of these answers and some of these products?" John Noseworthy asks.
Over-the-counter status would give the FDA more tools to look at the safety and benefits of e-cigarettes.
Find out what's next at the FDA when CNBC's Meg Tirrell speaks with commissioner Gottlieb at Healthy Returns.
Craig Venter, the geneticist who mapped the human genome in 2000, believes he can help people live to 100, maybe beyond.
Big pharma is rushing to close its innovation gap by investing in start-ups that can help them develop new drugs.
Luke Dow is an assistant professor of biochemistry at Weill Cornell Medicine.
The FDA will soon take steps aimed at curbing e-cigarette use among younger people, FDA chief Dr. Scott Gottlieb says.
CVS Health shattered expectations when it would acquire Aetna in a $69 billion deal.
The Berkshire Hathaway-Amazon-JP Morgan health-care alliance will disappoint if it does no more than focus on costs.
Political forces are working against the urgent need to step up breakthroughs for diseases like Alzheimer's and cancer.
A look at 50 private companies set to reshape the business landscape.
For investors who are addressing social and environmental issues, while generating financial returns.
Automation, AI and machine learning will radically influence the relationship between employers and their workforce.
Invest in You: Ready. Set. Grow. is focused on improving Americans’ money knowledge of saving, spending and investing.
Executives reflect on their own “Make or Break” moments, sharing how they have made key decisions, who they turn to for advice and what they would have done differently.
Where headlines become opportunities.
Rising Risks looks at the real estate impact of rising tides and increasingly extreme weather.
Cutting across various industries and the public sector, CNBC's Technology Executive Council offers insight on pressing issues facing tech.
A fixed-income strategy is key for investors who are retired or are approaching retirement. This special report details the range of tools and strategies used to manage a fixed income portfolio.
The buzz on the trading floor
ETF Edge, hosted by Bob Pisani, is dedicated to the fastest growing investing trend right now: ETFs.
Frontline insights and unique views on key issues and challenges facing today’s CFOs.
CNBC investigates the internet of things to see how “smart environments” are disrupting different industries across the globe.
“Options Action" features option traders from some of the top firms on Wall Street.
CNBC's "Futures Now," is the first multi-platform media experience entirely devoted to the futures market.
The latest CNBC Fed Survey.
Investigating energy innovations that can improve the way we live, work and play.
The latest news from the Squawk Box team on investing and business.
CNBC presents a one-day event that brings together top health care investors, CEOs and technologists to explore the innovations that will drive better outcomes, financially and clinically.
Every health care company seeks to scale the best technology and develop profitable ways to cover the massive cost of research and development, investors are looking for actionable intelligence on who’s breaking through, and patients are hungry for affordable and effective care. Healthy Returns is a convening of leaders who are improving patient outcomes, maximizing innovation, building great new companies and reinventing incumbents.
Led by CNBC’s anchors and reporters and with input from a world-class advisory board, Healthy Returns will hone in on groundbreaking ideas that will transform the health care industry, cutting through the noise and weeding out the "sales pitch."